Matthew Strobeck has bought stock on 7 days since Feb 2016
Director at QuidelOrtho Corporation, and 2 other companies
SEC CIK 0001377832 · Filings on SEC.gov ↗
Matthew Strobeck's record
3 months after each buy, from the first price a copier could get.
4 buys since 2016 with 3 months of prices.
Companies
Every filing
7 filings since Feb 2016, newest first
Quidelortho Corp
Director
Biodesix Inc
Director
Biodesix Inc
Director
Biodesix Inc
Director
Biodesix Inc
Director
Accelerate Diagnostics, Inc
Director
Accelerate Diagnostics, Inc
Director
About Matthew Strobeck
Matthew W. Strobeck, Ph.D. is a corporate director and Managing Partner at Birchview Capital.( He has served as a member of the Board of Directors at QuidelOrtho Corporation (NASDAQ: QDEL) for eight years, recently acquiring 10,000 shares at $23.96 per share, bringing his holdings to 27,775 shares.( On January 30, 2026, Dr. Strobeck notified the board of his decision not to stand for re-election at the 2026 annual stockholders' meeting due to other professional commitments, after which the board size will reduce from eleven to ten members; his departure is not due to any dispute with the company.(
Dr. Strobeck's tenure at QuidelOrtho highlights his expertise in corporate governance and investment, though specific prior career details and education beyond his Ph.D. are not detailed in available sources.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.